Quick highlights
- Detects antibodies/complement attached to RBCs (DAT)
- Supports evaluation of immune hemolysis and transfusion reaction contexts
- Interpreted with CBC, reticulocytes, bilirubin, LDH, and smear
- No fasting; EDTA blood sample
- Positive DAT does not always equal active hemolysis—clinical context matters
- Useful in autoimmune hemolytic anemia workups under clinician care
- May be used in newborn hemolysis evaluation when ordered
- Home blood collection available in many service areas
- Non-alarmist explanation with urgent red flags
- SEO coverage: direct Coombs test, DAT test, hemolytic anemia test
What’s included
Preparation
- Book blood draw (home or lab)
- No fasting required
- Disclose recent transfusions and pregnancy history if relevant
- Inform clinician about anemia symptoms and jaundice/dark urine
- Collect EDTA blood sample via trained phlebotomist
- Download report from <a href='/my-account/'>View reports</a>
- Review with clinician alongside CBC and hemolysis markers
- Seek urgent care if severe symptoms occur
FAQs
It detects antibodies/complement attached to red blood cells.
No.
To evaluate suspected immune hemolysis, transfusion reactions, or certain newborn hemolysis scenarios.
Not always. Clinicians interpret with hemolysis markers and symptoms.
CBC, reticulocyte count, bilirubin, LDH, haptoglobin, and peripheral smear.
Yes; recent transfusions can influence results; disclose transfusion history.
Often same day or within 24 hours.
EDTA whole blood.
Yes in many serviceable areas.
Jaundice, dark urine, pallor, severe weakness—seek medical evaluation.
Yes, in selected contexts when clinicians evaluate hemolytic disease of the newborn.
Some medicines can be associated with DAT positivity; clinicians review medication history.
Download from <a href='/my-account/'>View reports</a>.
It detects antibodies in serum (not attached to RBCs) and is used in different contexts like crossmatching; clinicians choose based on need.
Notes
Positive results require hematology interpretation.
